Male scientist working in lab

Study and training

There is a plethora of opportunity for career development at the MRC CDSS. The collaborative nature of work, the industry-leading facilities and knowledge sharing ethos here means endless possibilities for researchers.

Our Centre nurtures talent to support the delivery of the next generation of drug safety scientists. Researchers are encouraged and supported in research funding applications, enabling a deeper look at specific research enquiries. Combined with access to a range of key industry and academic links, the learning environment at the MRC CDSS is unparalleled.

The experience of our researchers demonstrates the opportunity and development available whilst working here, from working with GlaxoSmithKline to travelling to the University of Melbourne to gain invaluable insights, the infrastructure paves the way for progression into a variety of desired career pathways.

Our researchers share their experiences with us:

Amy Chadwick

Dr Amy Chadwick

Amy joined the MRC CDSS after her PhD and is now a lecturer in Pharmacology.

Vincent Yip

Dr Vincent Yip

Vincent completed a MRC Fellowship and is now a NIHR Clinical Lecturer in Clinical Pharmacology.

Amy Ball

Dr Amy Ball

Amy completed a MRC Industrial CASE Studentship with GlaxoSmithKline.

Listen to what our researchers have to say in the video below:

Postgraduate Training in Drug Safety Science

The MRC CDSS welcomes applications for both basic and clinical studentships from individuals with a strong academic background in a related area and a commitment to progressing their training in the field of drug safety. We have postgraduate training schemes set up in the following areas:

  • Opportunities in basic research
  • Opportunities in clinical research
  • Sabbaticals

If you are interested in any of these opportunities please email


We currently have a 4 year PhD opportunity, to identify microbial species that interact with IgA-producing cells in the gut in patients presenting with severe immune-related adverse events from immunotherapy with checkpoint inhibitors (CPI).

The student will learn molecular biology methods (DNA extraction, Next-generation Sequencing), cellular and immunoassays and bioinformatics. The project will be supervised by Prof. Munir Pirmohamed and Dr. Vanessa Fontana (University of Liverpool, MRC Centre for Drug Safety Science) and Dr. Gregory Amos and Dr Sjoerd Rijpkema (The National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare Products Regulatory agency).

Click here for more information. The application deadline is 26 July 2019.